Showing results (141-150 of 267) with videos related to

Sort By:
Pageof 27
ACS Nano|September 12, 2018
Surface-Enhanced Raman Scattering Nanoparticles for Multiplexed Imaging of Bladder Cancer Tissue Permeability and Molecular PhenotypeRyan M Davis, Bernhard Kiss, Dharati R Trivedi, et al.
The Review of Scientific Instruments|October 3, 2019
First results from the implementation of the ITER diagnostic residual gas analyzer prototype at Wendelstein 7-XG Schlisio, C C Klepper, J H Harris, et al.
Kidney International|January 20, 1999
Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase CT Heitzer, U Wenzel, U Hink, et al.
Viruses|January 8, 2025
Comparative Evaluation of Open-Source Bioinformatics Pipelines for Full-Length Viral Genome AssemblyLevente Zsichla, Marius Zeeb, Dávid Fazekas, et al.
Scientific Reports|September 30, 2020
Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis CSylwia Osuch, Tomasz Laskus, Hanna Berak, et al.
Peerj|December 7, 2020
HIV-1 promoter is gradually silenced when integrated into BACH2 in Jurkat T-cellsAnne Inderbitzin, Yik Lim Kok, Lisa Jörimann, et al.
Viruses|April 3, 2021
A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary CellsAudrey E Rindler, Herbert Kuster, Kathrin Neumann, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2007
Persistence of lamivudine-sensitive HIV-1 quasispecies in the presence of lamivudine in vitro and in vivoKristina Allers, Stefanie A Knoepfel, Pia Rauch, et al.
Thrombosis Research|July 9, 2013
Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIIISabine B Zollner, Elmar Raquet, Jochen Müller-Cohrs, et al.
British Journal of Pharmacology|September 24, 2010
5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activityA S Fischer, J Metzner, S D Steinbrink, et al.
Pageof 27